Hence, Sec62 has been suggested as a potential cancer marker, cancer-causing, or anti-cancer drug resistant factor, although whether the expression levels of Sec62 influence protein translocation and how the changes of its abundance are related to cell physiology and the development of diseases remain elusive. This evidence concerns the gene SEC62 and cancer.